BL Pharmtech (065170) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, BL Pharmtech (065170) reported revenue of 6.5 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20256.5 billion KRW-2.8 billion KRW-16.8 billion KRW[source]
20248.8 billion KRW-3.2 billion KRW-5.7 billion KRW[source]
202324.5 billion KRW-6.8 billion KRW142 million KRW[source]
202280.6 billion KRW-2.8 billion KRW-13.6 billion KRW[source]
202184.4 billion KRW-3.4 billion KRW-20.1 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202516.3 billion KRW9.3 billion KRW7.0 billion KRW[source]
202434.2 billion KRW11.2 billion KRW22.9 billion KRW[source]
202342.8 billion KRW11.4 billion KRW31.3 billion KRW[source]
202262.9 billion KRW25.2 billion KRW37.7 billion KRW[source]
202184.5 billion KRW22.6 billion KRW61.9 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice